Recursion Pharmaceuticals shares surge on AI model release RXRX hereremove ads Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Click Subscribe #RecursionPharmaceuticals #AIStrategy #Pharmaceuticals #StockMarket #InvestmentNews

Why Recursion Pharmaceuticals Stock Was Getting Mashed on Monday - Yahoo Finance Why Recursion Pharmaceuticals Stock Was Getting Mashed on Monday  Yahoo Finance

Click Subscribe #RecursionPharmaceuticals #PharmaStocks #StockMarket #InvestmentNews #Finance

Why Recursion Pharmaceuticals Stock Is Skyrocketing Today - Yahoo Finance Why Recursion Pharmaceuticals Stock Is Skyrocketing Today  Yahoo Finance

Click Subscribe #StockMarket #Investing #FinanceNews #Pharmaceuticals #RecursionPharmaceuticals

For three weeks last May, employees of the AI giant Nvidia and Recursion Pharmaceuticals slept on the floor of a data center in Salt Lake City. They were there to build a machine that Recursion, a decade-old biotech company, believes will give it an edge in the contest to develop the next great new medicines: BioHive-2, the largest and fastest supercomputer owned by a biopharma. It’s an audacious bet that the future of America’s pharmaceutical industry will be as much about computing power as it is about scientific talent. https://fortune.com/2025/04/03/recursion-pharmaceuticals-ai-drug-discovery/

#RXRX #RecursionPharmaceuticals

Will #AI ever cure #cancer?

The multibillion-dollar race to bring the first #AI-discovered #drug to market

fortune.com/2025/04/03/r...

Recursion Pharma Accelerator Steps In to Fill Some of the Funding Gap Amid NIH Tumult - MedCity News Altitude Lab Fund will provide pre-seed funding for early-stage startups affected by changes to grant programs administered by the National Institutes of Health. Accepted applicants will be admitted t...

#Altitude Lab Fund will provide pre-seed funding for early-stage startups affected by changes to grant programs administered by the National Institutes of #Health. Accepted applicants will be admitted to #AltitudeLab, the Salt Lake City #biotech accelerator formed by #RecursionPharmaceuticals